Commerzbank Aktiengesellschaft’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-16,720	Closed	-$252K	–	1011
2016 Q4	$252K	Sell	16,720 -27,499	-62%	-$363K	﹤0.01%	838
2016 Q3	$517K	Sell	44,219 -640	-1%	-$7.53K	0.01%	561
2016 Q2	$484	Sell	44,859 -6,386	-12%	-$65.9K	﹤0.01%	685
2016 Q1	$474K	Buy	51,245 +20,605	+67%	+$222K	﹤0.01%	710
2015 Q4	$455K	Buy	30,640 +12,754	+71%	+$213K	﹤0.01%	905
2015 Q3	$294K	Buy	17,886 +753	+4%	+$15.4K	﹤0.01%	958
2015 Q2	$391K	Sell	17,133 -953	-5%	-$19K	﹤0.01%	1036
2015 Q1	$275K	Buy	+18,086	New	+$235K	﹤0.01%	1042
2014 Q2	–	Sell	-19,089	Closed	-$222K	–	1249
2014 Q1	$222K	Buy	+19,089	New	+$323K	﹤0.01%	1144

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Commerzbank Aktiengesellschaft's MNTA Position: Q1 2017 in Review

Commerzbank Aktiengesellschaft sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2017, closing a stake of 16,720 shares — an estimated $252K sold.

Commerzbank Aktiengesellschaft first reported a position in MNTA in Q1 2014 and held it in 9 quarters. The position peaked at $517K in Q3 2016. 162 funds tracked by Wall St. Rank hold MNTA as of Q1 2017.

Commerzbank Aktiengesellschaft reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 16,720 Momenta Pharmaceuticals, Inc. shares in Q1 2017, an estimated $252K.
Commerzbank Aktiengesellschaft first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 9 quarters.
Commerzbank Aktiengesellschaft's Momenta Pharmaceuticals, Inc. position peaked at $517K in Q3 2016.
162 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2017, filed 1 May 2017.